Subgroup analysis involving direct comparisons revealed that compared to CT alone, anti‐PD‐1 + CT, but not anti‐PD‐L1 + CT, significantly prolonged OS in patients with SCLC with LM. This evidence concerns the gene PDCD1 and small cell lung carcinoma.